Selected research
Industry Research
NBL1 ELISA Kit Industry Research Report 2026
Market perspective
The global NBL1 ELISA Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NBL1 ELISA Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NBL1 ELISA Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NBL1 ELISA Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NBL1 ELISA Kit include Wuhan Fine Biotech Co., Ltd., Thermo Fisher Scientific (China) Co., Ltd., Merck, Boster Biological Technology, Sino Biological, Inc., RayBiotech, Inc., MyBiosource, Inc., LifeSpan BioSciences, Inc and Innovative Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NBL1 ELISA Kit market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NBL1 ELISA Kit Market by Company
Wuhan Fine Biotech Co., Ltd.
Thermo Fisher Scientific (China) Co., Ltd.
Merck
Boster Biological Technology
Sino Biological, Inc.
RayBiotech, Inc.
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Innovative Research
Geno Technology, Inc.
CUSABIO
Creative Diagnostics
Cell Signaling Technology, Inc.
Bio-Techne
Biorbyt
Assay Genie
Abbexa
Abcam
NBL1 ELISA Kit Segment by Type
Mouse
Human
Rat
Other
NBL1 ELISA Kit Segment by Application
Hospital
Research Institute
Other
NBL1 ELISA Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NBL1 ELISA Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NBL1 ELISA Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NBL1 ELISA Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NBL1 ELISA Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NBL1 ELISA Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NBL1 ELISA Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mouse
- Human
- Rat
- Other
Applications
- Hospital
- Research Institute
- Other
Companies covered
- Wuhan Fine Biotech Co., Ltd.
- Thermo Fisher Scientific (China) Co., Ltd.
- Merck
- Boster Biological Technology
- Sino Biological, Inc.
- RayBiotech, Inc.
- MyBiosource, Inc.
- LifeSpan BioSciences, Inc
- Innovative Research
- Geno Technology, Inc.
- CUSABIO
- Creative Diagnostics
- Cell Signaling Technology, Inc.
- Bio-Techne
- Biorbyt
- Assay Genie
- Abbexa
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global NBL1 ELISA Kit Market Size (2021-2032)
- 2.2.2 Global NBL1 ELISA Kit Sales (2021-2032)
- 2.2.3 Global NBL1 ELISA Kit Market Average Price (2021-2032)
- 2.3 NBL1 ELISA Kit by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mouse
- 2.3.3 Human
- 2.3.4 Rat
- 2.3.5 Other
- 2.4 NBL1 ELISA Kit by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Research Institute
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NBL1 ELISA Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global NBL1 ELISA Kit Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global NBL1 ELISA Kit Revenue of Manufacturers (2021-2026)
- 3.4 Global NBL1 ELISA Kit Average Price by Manufacturers (2021-2026)
- 3.5 Global NBL1 ELISA Kit Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of NBL1 ELISA Kit, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of NBL1 ELISA Kit, Product Type & Application
- 3.8 Global Manufacturers of NBL1 ELISA Kit, Established Date
- 3.9 Global NBL1 ELISA Kit Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Fine Biotech Co., Ltd.
- 4.1.1 Wuhan Fine Biotech Co., Ltd. Company Information
- 4.1.2 Wuhan Fine Biotech Co., Ltd. Business Overview
- 4.1.3 Wuhan Fine Biotech Co., Ltd. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Fine Biotech Co., Ltd. NBL1 ELISA Kit Product Portfolio
- 4.1.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
- 4.2 Thermo Fisher Scientific (China) Co., Ltd.
- 4.2.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
- 4.2.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
- 4.2.3 Thermo Fisher Scientific (China) Co., Ltd. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific (China) Co., Ltd. NBL1 ELISA Kit Product Portfolio
- 4.2.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck NBL1 ELISA Kit Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Boster Biological Technology
- 4.4.1 Boster Biological Technology Company Information
- 4.4.2 Boster Biological Technology Business Overview
- 4.4.3 Boster Biological Technology NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boster Biological Technology NBL1 ELISA Kit Product Portfolio
- 4.4.5 Boster Biological Technology Recent Developments
- 4.5 Sino Biological, Inc.
- 4.5.1 Sino Biological, Inc. Company Information
- 4.5.2 Sino Biological, Inc. Business Overview
- 4.5.3 Sino Biological, Inc. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sino Biological, Inc. NBL1 ELISA Kit Product Portfolio
- 4.5.5 Sino Biological, Inc. Recent Developments
- 4.6 RayBiotech, Inc.
- 4.6.1 RayBiotech, Inc. Company Information
- 4.6.2 RayBiotech, Inc. Business Overview
- 4.6.3 RayBiotech, Inc. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 RayBiotech, Inc. NBL1 ELISA Kit Product Portfolio
- 4.6.5 RayBiotech, Inc. Recent Developments
- 4.7 MyBiosource, Inc.
- 4.7.1 MyBiosource, Inc. Company Information
- 4.7.2 MyBiosource, Inc. Business Overview
- 4.7.3 MyBiosource, Inc. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MyBiosource, Inc. NBL1 ELISA Kit Product Portfolio
- 4.7.5 MyBiosource, Inc. Recent Developments
- 4.8 LifeSpan BioSciences, Inc
- 4.8.1 LifeSpan BioSciences, Inc Company Information
- 4.8.2 LifeSpan BioSciences, Inc Business Overview
- 4.8.3 LifeSpan BioSciences, Inc NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 LifeSpan BioSciences, Inc NBL1 ELISA Kit Product Portfolio
- 4.8.5 LifeSpan BioSciences, Inc Recent Developments
- 4.9 Innovative Research
- 4.9.1 Innovative Research Company Information
- 4.9.2 Innovative Research Business Overview
- 4.9.3 Innovative Research NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Innovative Research NBL1 ELISA Kit Product Portfolio
- 4.9.5 Innovative Research Recent Developments
- 4.10 Geno Technology, Inc.
- 4.10.1 Geno Technology, Inc. Company Information
- 4.10.2 Geno Technology, Inc. Business Overview
- 4.10.3 Geno Technology, Inc. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Geno Technology, Inc. NBL1 ELISA Kit Product Portfolio
- 4.10.5 Geno Technology, Inc. Recent Developments
- 4.11 CUSABIO
- 4.11.1 CUSABIO Company Information
- 4.11.2 CUSABIO Business Overview
- 4.11.3 CUSABIO NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CUSABIO NBL1 ELISA Kit Product Portfolio
- 4.11.5 CUSABIO Recent Developments
- 4.12 Creative Diagnostics
- 4.12.1 Creative Diagnostics Company Information
- 4.12.2 Creative Diagnostics Business Overview
- 4.12.3 Creative Diagnostics NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Creative Diagnostics NBL1 ELISA Kit Product Portfolio
- 4.12.5 Creative Diagnostics Recent Developments
- 4.13 Cell Signaling Technology, Inc.
- 4.13.1 Cell Signaling Technology, Inc. Company Information
- 4.13.2 Cell Signaling Technology, Inc. Business Overview
- 4.13.3 Cell Signaling Technology, Inc. NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cell Signaling Technology, Inc. NBL1 ELISA Kit Product Portfolio
- 4.13.5 Cell Signaling Technology, Inc. Recent Developments
- 4.14 Bio-Techne
- 4.14.1 Bio-Techne Company Information
- 4.14.2 Bio-Techne Business Overview
- 4.14.3 Bio-Techne NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bio-Techne NBL1 ELISA Kit Product Portfolio
- 4.14.5 Bio-Techne Recent Developments
- 4.15 Biorbyt
- 4.15.1 Biorbyt Company Information
- 4.15.2 Biorbyt Business Overview
- 4.15.3 Biorbyt NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Biorbyt NBL1 ELISA Kit Product Portfolio
- 4.15.5 Biorbyt Recent Developments
- 4.16 Assay Genie
- 4.16.1 Assay Genie Company Information
- 4.16.2 Assay Genie Business Overview
- 4.16.3 Assay Genie NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Assay Genie NBL1 ELISA Kit Product Portfolio
- 4.16.5 Assay Genie Recent Developments
- 4.17 Abbexa
- 4.17.1 Abbexa Company Information
- 4.17.2 Abbexa Business Overview
- 4.17.3 Abbexa NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Abbexa NBL1 ELISA Kit Product Portfolio
- 4.17.5 Abbexa Recent Developments
- 4.18 Abcam
- 4.18.1 Abcam Company Information
- 4.18.2 Abcam Business Overview
- 4.18.3 Abcam NBL1 ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Abcam NBL1 ELISA Kit Product Portfolio
- 4.18.5 Abcam Recent Developments
5 Global NBL1 ELISA Kit Market Scenario by Region
- 5.1 Global NBL1 ELISA Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global NBL1 ELISA Kit Sales by Region: 2021-2032
- 5.2.1 Global NBL1 ELISA Kit Sales by Region: 2021-2026
- 5.2.2 Global NBL1 ELISA Kit Sales by Region: 2027-2032
- 5.3 Global NBL1 ELISA Kit Revenue by Region: 2021-2032
- 5.3.1 Global NBL1 ELISA Kit Revenue by Region: 2021-2026
- 5.3.2 Global NBL1 ELISA Kit Revenue by Region: 2027-2032
- 5.4 North America NBL1 ELISA Kit Market Facts & Figures by Country
- 5.4.1 North America NBL1 ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America NBL1 ELISA Kit Sales by Country (2021-2032)
- 5.4.3 North America NBL1 ELISA Kit Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe NBL1 ELISA Kit Market Facts & Figures by Country
- 5.5.1 Europe NBL1 ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe NBL1 ELISA Kit Sales by Country (2021-2032)
- 5.5.3 Europe NBL1 ELISA Kit Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific NBL1 ELISA Kit Market Facts & Figures by Country
- 5.6.1 Asia Pacific NBL1 ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific NBL1 ELISA Kit Sales by Country (2021-2032)
- 5.6.3 Asia Pacific NBL1 ELISA Kit Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America NBL1 ELISA Kit Market Facts & Figures by Country
- 5.7.1 South America NBL1 ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America NBL1 ELISA Kit Sales by Country (2021-2032)
- 5.7.3 South America NBL1 ELISA Kit Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa NBL1 ELISA Kit Market Facts & Figures by Country
- 5.8.1 Middle East and Africa NBL1 ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa NBL1 ELISA Kit Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa NBL1 ELISA Kit Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global NBL1 ELISA Kit Sales by Type (2021-2032)
- 6.1.1 Global NBL1 ELISA Kit Sales by Type (2021-2032) & (k units)
- 6.1.2 Global NBL1 ELISA Kit Sales Market Share by Type (2021-2032)
- 6.2 Global NBL1 ELISA Kit Revenue by Type (2021-2032)
- 6.2.1 Global NBL1 ELISA Kit Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global NBL1 ELISA Kit Revenue Market Share by Type (2021-2032)
- 6.3 Global NBL1 ELISA Kit Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global NBL1 ELISA Kit Sales by Application (2021-2032)
- 7.1.1 Global NBL1 ELISA Kit Sales by Application (2021-2032) & (k units)
- 7.1.2 Global NBL1 ELISA Kit Sales Market Share by Application (2021-2032)
- 7.2 Global NBL1 ELISA Kit Revenue by Application (2021-2032)
- 7.2.1 Global NBL1 ELISA Kit Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global NBL1 ELISA Kit Revenue Market Share by Application (2021-2032)
- 7.3 Global NBL1 ELISA Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 NBL1 ELISA Kit Value Chain Analysis
- 8.1.1 NBL1 ELISA Kit Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 NBL1 ELISA Kit Production Mode & Process
- 8.2 NBL1 ELISA Kit Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 NBL1 ELISA Kit Distributors
- 8.2.3 NBL1 ELISA Kit Customers
9 Global NBL1 ELISA Kit Analyzing Market Dynamics
- 9.1 NBL1 ELISA Kit Industry Trends
- 9.2 NBL1 ELISA Kit Industry Drivers
- 9.3 NBL1 ELISA Kit Industry Opportunities and Challenges
- 9.4 NBL1 ELISA Kit Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst